Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 7, 2014
A polyaxonal amacrine cell population in the primate retina
Martin Greschner, Greg D Field, Peter H Li, et al.
JCO Precision Oncology
|
January 10, 2022
Isocitrate Dehydrogenase-Mutated Cholangiocarcinoma: Natural History and Clinical Outcomes
Grant Wintheiser, Tyler Zemla, Qian Shi, et al.
Pancreas
|
February 4, 2020
Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United States
Afsaneh Barzi, Rebecca Miksad, Andy Surinach, et al.
Nature Chemical Biology
|
November 20, 2019
ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5
Yang Cao, Tian Qiu, Rahul S Kathayat, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 20, 2015
Anatomical identification of extracellularly recorded cells in large-scale multielectrode recordings
Peter H Li, Jeffrey L Gauthier, Max Schiff, et al.
Cancer Research
|
August 3, 2002
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene
Roberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, et al.
World Journal of Clinical Oncology
|
September 13, 2023
Targeting <i>KRAS</i> in pancreatic adenocarcinoma: Progress in demystifying the holy grail
Ahmed Elhariri, Ahmed Alhaj, Daniel Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2016
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer
Matthew R Farren, Thomas A Mace, Susan Geyer, et al.
JCO Precision Oncology
|
April 9, 2026
Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World Experience
Oluseyi Abidoye, Angelo Pirozzi, Naohiro Okano, et al.
Hepatology (Baltimore, Md.)
|
September 24, 2022
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study
Mitesh J Borad, Li-Yuan Bai, Donald Richards, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 7, 2014
A polyaxonal amacrine cell population in the primate retina
Martin Greschner, Greg D Field, Peter H Li, et al.
JCO Precision Oncology
|
January 10, 2022
Isocitrate Dehydrogenase-Mutated Cholangiocarcinoma: Natural History and Clinical Outcomes
Grant Wintheiser, Tyler Zemla, Qian Shi, et al.
Pancreas
|
February 4, 2020
Real-World Dosing Patterns and Outcomes of Patients With Metastatic Pancreatic Cancer Treated With a Liposomal Irinotecan Regimen in the United States
Afsaneh Barzi, Rebecca Miksad, Andy Surinach, et al.
Nature Chemical Biology
|
November 20, 2019
ABHD10 is an S-depalmitoylase affecting redox homeostasis through peroxiredoxin-5
Yang Cao, Tian Qiu, Rahul S Kathayat, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 20, 2015
Anatomical identification of extracellularly recorded cells in large-scale multielectrode recordings
Peter H Li, Jeffrey L Gauthier, Max Schiff, et al.
Cancer Research
|
August 3, 2002
The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene
Roberto Diaz, Daniel Ahn, Lluis Lopez-Barcons, et al.
World Journal of Clinical Oncology
|
September 13, 2023
Targeting <i>KRAS</i> in pancreatic adenocarcinoma: Progress in demystifying the holy grail
Ahmed Elhariri, Ahmed Alhaj, Daniel Ahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 1, 2016
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer
Matthew R Farren, Thomas A Mace, Susan Geyer, et al.
JCO Precision Oncology
|
April 9, 2026
Bespoke Circulating Tumor DNA Testing for Diagnostic Resolution, Disease Surveillance, and Treatment Monitoring in Hepatopancreatobiliary Malignancies: A Real-World Experience
Oluseyi Abidoye, Angelo Pirozzi, Naohiro Okano, et al.
Hepatology (Baltimore, Md.)
|
September 24, 2022
Silmitasertib plus gemcitabine and cisplatin first-line therapy in locally advanced/metastatic cholangiocarcinoma: A Phase 1b/2 study
Mitesh J Borad, Li-Yuan Bai, Donald Richards, et al.
Page
of 6